PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.
about
Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer.Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
P2860
PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PARP inhibitor increases chemo ...... triple-negative breast cancer.
@en
PARP inhibitor increases chemo ...... triple-negative breast cancer.
@nl
type
label
PARP inhibitor increases chemo ...... triple-negative breast cancer.
@en
PARP inhibitor increases chemo ...... triple-negative breast cancer.
@nl
prefLabel
PARP inhibitor increases chemo ...... triple-negative breast cancer.
@en
PARP inhibitor increases chemo ...... triple-negative breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
PARP inhibitor increases chemo ...... triple-negative breast cancer.
@en
P2093
Wenwen Zhang
Xiaoxiang Guan
P2860
P2888
P356
10.1038/SREP42319
P407
P577
2017-02-08T00:00:00Z